<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34797624</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>15</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>12</Month>
        <Day>15</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1944-8252</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>13</Volume>
            <Issue>48</Issue>
            <PubDate>
              <Year>2021</Year>
              <Month>Dec</Month>
              <Day>08</Day>
            </PubDate>
          </JournalIssue>
          <Title>ACS applied materials &amp; interfaces</Title>
          <ISOAbbreviation>ACS Appl Mater Interfaces</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Protective Face Masks: Current Status and Future Trends.</ArticleTitle>
        <Pagination>
          <StartPage>56725</StartPage>
          <EndPage>56751</EndPage>
          <MedlinePgn>56725-56751</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1021/acsami.1c12227</ELocationID>
        <Abstract>
          <AbstractText>Management of the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has relied in part on the use of personal protective equipment (PPE). Face masks, as a representative example of PPE, have made a particularly significant contribution. However, most commonly used face masks are made of materials lacking inactivation properties against either SARS-CoV-2 or multidrug-resistant bacteria. Therefore, symptomatic and asymptomatic individuals wearing masks can still infect others due to viable microbial loads escaping from the masks. Moreover, microbial contact transmission can occur by touching the mask, and the discarded masks are an increasing source of contaminated biological waste and a serious environmental threat. For this reason, during the current pandemic, many researchers have worked to develop face masks made of advanced materials with intrinsic antimicrobial, self-cleaning, reusable, and/or biodegradable properties, thereby providing extra protection against pathogens in a sustainable manner. To overview this segment of the remarkable efforts against COVID-19, this review describes the different types of commercialized face masks, their main fabrication methods and treatments, and the progress achieved in face mask development.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Tuñón-Molina</LastName>
            <ForeName>Alberto</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-3819-7390</Identifier>
            <AffiliationInfo>
              <Affiliation>Biomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia San Vicente Mártir, c/Guillem de Castro 94, 46001 Valencia, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Takayama</LastName>
            <ForeName>Kazuo</ForeName>
            <Initials>K</Initials>
            <Identifier Source="ORCID">0000-0002-1132-2457</Identifier>
            <AffiliationInfo>
              <Affiliation>Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto 606-8507, Japan.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Redwan</LastName>
            <ForeName>Elrashdy M</ForeName>
            <Initials>EM</Initials>
            <Identifier Source="ORCID">0000-0001-8246-0075</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Science, Department of Biological Science, King Abdulaziz University, Jeddah 21589, Saudi Arabia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Uversky</LastName>
            <ForeName>Vladimir N</ForeName>
            <Initials>VN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, Florida 33612, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Andrés</LastName>
            <ForeName>Juan</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0003-0232-3957</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Physical and Analytical Chemistry, University Jaume I (UJI), 12071 Castellon, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Serrano-Aroca</LastName>
            <ForeName>Ángel</ForeName>
            <Initials>Á</Initials>
            <Identifier Source="ORCID">0000-0002-9953-3848</Identifier>
            <AffiliationInfo>
              <Affiliation>Biomaterials and Bioengineering Lab, Centro de Investigación Traslacional San Alberto Magno, Universidad Católica de Valencia San Vicente Mártir, c/Guillem de Castro 94, 46001 Valencia, Valencia, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>19</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>ACS Appl Mater Interfaces</MedlineTA>
        <NlmUniqueID>101504991</NlmUniqueID>
        <ISSNLinking>1944-8244</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001673" MajorTopicYN="N">Biodegradation, Environmental</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName>
          <QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName>
          <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024901" MajorTopicYN="N">Drug Resistance, Multiple, Bacterial</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008397" MajorTopicYN="N">Masks</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059027" MajorTopicYN="N">Recycling</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
        <Keyword MajorTopicYN="N">aerosol</Keyword>
        <Keyword MajorTopicYN="N">antimicrobial materials</Keyword>
        <Keyword MajorTopicYN="N">bacterial filtration</Keyword>
        <Keyword MajorTopicYN="N">bio-derived materials</Keyword>
        <Keyword MajorTopicYN="N">breathability</Keyword>
        <Keyword MajorTopicYN="N">coronavirus</Keyword>
        <Keyword MajorTopicYN="N">face mask</Keyword>
        <Keyword MajorTopicYN="N">particle filtration</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>16</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>19</Day>
          <Hour>17</Hour>
          <Minute>9</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34797624</ArticleId>
        <ArticleId IdType="doi">10.1021/acsami.1c12227</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
